- Anders will be responsible for setting and executing Deep Branch’s research and development strategy and protecting the intellectual property of its ingredients and technology.
- He will also lead in forming external research and development partnerships for the company.
- Anders has worked within biotech for over 25 years and has significant private sector and academic experience across multiple industries.
Deep Branch has appointed Anders Clausen as its new Chief Innovation Officer. Anders will oversee the company’s technical leadership team in setting and executing its research and development strategy and ensuring Deep Branch holds robust intellectual property for its technology platform and products. He will also lead in establishing external research and development collaborations for the business.
- With over 25 years of working in biotechnology, Anders brings vast experience in bioprocess technology development and application development for microbes in food. He joins the company after founding Productus, a business dedicated to providing guidance on research and development strategy and production process development within bioscience. Prior to this, Anders spent over a decade with market-leading cultures and probiotics producer Chr. Hansen, primarily focusing on developing new products and production platform technologies for stabilising lactic acid bacteria as starter cultures and probiotics.
Anders has extensive knowledge in developing and implementing fermentation and downstream processes for microorganisms through rapid up and downscaling. He is also experienced in managing innovation and technology development through collaboration between the private sector and academia.
Commenting on joining Deep Branch, Anders said:
“The microbial protein sector is still in its infancy. However, it’s clear that Deep Branch will play a crucial role in shaping its maturity. We’re ideally placed to define the opportunities for single-cell protein globally and unlock the potential of gas fermentation by solving the remaining technical and engineering challenges. Joining Deep Branch on this journey is incredibly exciting given the scientific and commercial opportunities it represents.”
Deep Branch’s CEO Pete Rowe added:
“Commercialising any technology is about more than good ideas – it requires strong execution. This is crucial in biotechnology because our development cycles are so long compared to other industries. Anders brings a wealth of experience in managing the commercialisation of new bioprocesses through their full innovation life-cycle. Coming from Chr. Hansen, he knows that innovation must consider all key stakeholders, and it’s clear that he works hard to ensure commitment from all parties to get to a win-win situation. Anders will be integral in bringing our (R)evolve™ gas fermentation platform to full maturity, ensuring we can commercialise products quickly, efficiently and with the ability to meet genuine market demand.”
Notes for editors
Link to images:
Lee Lodge, Head of PR, Life Size Media
Tel. +44 07812076914
About Deep Branch:
Deep Branch creates sustainable, high-value food and feed ingredients to support a more sustainable food system. The company’s proprietary [platform name] technology uses CO2 and hydrogen as clean and renewable carbon and energy sources to deliver next-generation bio-based products.
Founded in 2018, Deep Branch has approximately 30 staff based in the UK and the Netherlands. It works with feed producers in industries such as aquaculture and partners with upstream companies such as CO2 suppliers to deploy its technology efficiently and safely. Deep Branch has already established relationships with major international stakeholders, including Drax, BioMar and Sainsbury’s.
For more information, visit: https://deepbranch.com/